Date Filed | Type | Description |
04/05/2023 |
SC 13D/A
| RTW INVESTMENTS, LP reports a 0% stake in Renovacor, Inc. |
02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
12/12/2022 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
12/06/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
12/06/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
12/01/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
12/01/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
12/01/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
12/01/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
12/01/2022 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta... |
12/01/2022 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
11/10/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
11/10/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
10/31/2022 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
10/14/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
10/14/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
09/23/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
09/23/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
09/22/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
09/21/2022 |
SC 13D
| RTW INVESTMENTS, LP reports a 19% stake in Renovacor, Inc. |
09/20/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
09/20/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
09/20/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
09/20/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
09/20/2022 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Agreement and Plan of Merger, by and among Renovacor, Inc, Rocket Pharmaceuticals, Inc., Merger Sub I and Merger Sub II",
"Form of Voting and Support Agreement between Renovacor, Inc. and the stockholders party thereto",
"Form of Voting and Support Agreement between Rocket Pharmaceuticals, Inc. and the stockholders party thereto",
"Rocket Pharmaceuticals to Acquire Renovacor, Extending Leadership in AAV-based Cardiac Gene Therapy" |
|
08/08/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
08/08/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
08/08/2022 |
8-K
| Quarterly results |
07/12/2022 |
8-K
| Quarterly results |
06/24/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
06/24/2022 |
8-K/A
| Quarterly results |
06/03/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
06/03/2022 |
8-K
| Quarterly results |
06/01/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
|